Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZX-7101A tablets in 5–11-year-old children with uncomplicated influenza
CTR20242819Phase 3Terminated
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Seloxavir marboxil in influenza, sponsored by Zenshine Pharmaceuticals Co., Ltd.. Started Aug 2024; status: terminated.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20242819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242819.